Advanced Pharmaceutical Bulletin, Nanoparticle-Based Drug Delivery
In nanoplatforms for cancer theranostics
Sara A. Abdel
Gaber
Scholar“Research focused on Nanoplatforms for cancer theranostics and adjacent fields.”
15
H-index
728
Citations
Sara has not officially claimed their profile. If you are Sara, claim it free.
Claim Your Profile
Pioneer
LOCKED

Pathfinder
LOCKED

Scholar
EARNED

Innovator
LOCKED

Inventor
LOCKED

Catalyst
LOCKED

Expert
UPGRADE
What I study
ara A. Abdel Gaber is a researcher working on Nanoplatforms for cancer theranostics. A fuller summary will appear once they update their profile.
Publication output and reach
Sara's work has been cited 728 times across 8 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Topics
Recent publications
29 worksPharmaceutics, Parasitic Infections and Diagnostics
Burns, Pharmacological Effects of Medicinal Plants
Journal of Biological Engineering, Wound Healing and Treatments
Journal of Biomolecular Structure and Dynamics, Computational Drug Discovery Methods
Journal of Drug Delivery Science and Technology, Silk-based biomaterials and applications
Pharmaceuticals, Curcumin's Biomedical Applications
Journal of Drug Delivery Science and Technology, Nanoparticle-Based Drug Delivery
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sara?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you